Maree Bilandzic Selected Research

betaglycan (TGFBR3)

11/2014	Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFκB-mediated induction of MMP2.
3/2013	Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.
8/2012	Reprint of: Betaglycan: a multifunctional accessory.
6/2011	Betaglycan: a multifunctional accessory.
4/2009	Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maree Bilandzic Research Topics

Disease

11	Neoplasms (Cancer) 09/2021 - 04/2009
8	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 01/2012
2	Carcinoma (Carcinomatosis) 01/2017 - 07/2013
2	Granulosa Cell Tumor 11/2014 - 04/2009
1	Neoplasm Metastasis (Metastasis) 11/2014
1	Prostatic Neoplasms (Prostate Cancer) 07/2013
1	Adenocarcinoma 07/2013
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 07/2013
1	Ascites 01/2012

Drug/Important Bio-Agent (IBA)

5	betaglycan (TGFBR3)IBA 11/2014 - 04/2009
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2017
2	Inhibins (Inhibin)IBA 08/2012 - 06/2011
1	PlasticsIBA 09/2021
1	Pharmaceutical PreparationsIBA 09/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2021
1	EnzymesIBA 10/2020
1	Tissue Inhibitor of Metalloproteinase-2IBA 10/2020
1	Metalloproteases (Metalloproteinases)IBA 10/2020
1	Keratin-14 (Keratin 14)IBA 08/2019
1	NexusIBA 12/2018
1	VaccinesIBA 12/2018
1	MesothelinIBA 01/2018
1	3-hydroxyphenyltrimethylammoniumIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Biological ProductsIBA 01/2017
1	ProteomeIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 07/2013
1	ThiosemicarbazonesIBA 07/2013
1	CopperIBA 07/2013
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 07/2013
1	AntigensIBA 01/2012
1	Keratin-7 (Cytokeratin 7)IBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	Epithelial Cell Adhesion MoleculeIBA 01/2012
1	NAD (NADH)IBA 01/2012

Therapy/Procedure

3	Therapeutics 09/2021 - 07/2013
1	Drug Therapy (Chemotherapy) 09/2021
1	Immunotherapy 12/2018
1	Injections 01/2012